Anthony Hunt

Director

Anthony Hunt (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Repligen Corporation (RGEN). The largest single filing was $3.8M of RGEN (24,536 sh across 4 lots, as filed), executed Nov 12 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.9M

shares × price, as filed

Last traded

Nov 13 2025

Filed Nov 14 2025

Median ADV $191.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $21.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

RGEN

Repligen Corporation RGEN · 0 buys · 6 sells 6 filings

Recent filings

RGENSALE Repligen Corporation View filing → $3.1M
20,000 sh across 7 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $3.8M
24,536 sh across 4 lots
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $3.5M
29,015 sh across 5 lots
Exec Sep 10 2025
Filed Sep 11 2025 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $3.2M
26,172 sh across 3 lots
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $4.1M
26,596 sh across 4 lots
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $3.4M
24,246 sh × $139.67
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET RGENSALE Repligen Corporation View filing → $3.1M
21,587 sh across 3 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET